CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project develops a hybrid technology that combines imaging-based physical characterization and near-infrared chemical imaging to assess particle size, shape, and moisture content in real-time during pharmaceutical manufacturing. This innovation aims to enhance process control, product quality, and patient safety i…
Particles and granules play a key role in process efficacy and final product quality for numerous industries including pharmaceuticals, food, nutritionals and cosmetics.
Particle physics governs process variables such as flow, blending, granulation, compression and coating.
These variables can have a significant effect on final product behaviour such as blend homogeneity, drug absorption rates, product robustness, etc.
The identified key physical parameters include particle/granule size and shap…
INNOPHARMA LABS LIMITED
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Ireland, DUBLIN
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Spain, Hospitalet Llobregat
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Finland, OULU
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
